Snapshot · Russell 3000 · generated 2026-09-19 21:52 UTC

RCKT — Rocket Pharmaceuticals, Inc.

UNDERVALUED (MOS +81.7%) · Quality 55/100

RCKT - Rocket Pharmaceuticals, Inc.
Data generated 2026-09-19 21:52 UTC (nightly scan, universe: Russell 3000).
Price: 3.37 USD
Intrinsic value: 18.41 USD
Margin of safety: +81.7%
Implied growth (reverse DCF): -17.8% (model assumes +5.0%)
Valuation: UNDERVALUED
Value Score: 44.7
Quality: 55/100
Moat score: 8 (erosion: none)
UNDERVALUED (MOS +81.7%) - Quality 55/100
Red flags: Intrinsic value rests on a default/estimated input.
Source: StocksDeepDive - https://stocksdeepdive.com/s/RCKT
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

3.37

Intrinsic value

18.41

Margin of safety

+81.7%

Implied growth (reverse DCF)

-17.8%

model assumes +5.0%

Value Score

44.7

Quality

Psychology

19.9

Discovery

9.5

price/volume attention only

Moat score

erosion: none

Value Score: top 23% of Russell 3000 · Quality: top 46%

Open the interactive Deep Dive for RCKT →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/RCKT - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is RCKT undervalued?

As of 2026-09-19, RCKT trades at 3.37 against a computed intrinsic value of 18.41 (+81.7% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Rocket Pharmaceuticals, Inc.'s Value Score?

Rocket Pharmaceuticals, Inc.'s Value Score is 44.7 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.